Finbud Financial (FINBUD)
Fast GrowerScore breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹132.5 |
| Market Cap | ₹200.02 Cr |
| P/E Ratio | 20.47 |
| ROCE | 33.95% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 37.63% |
| Debt/Equity | — |
| Sales Growth | 35.74% |
| Promoter Holding | 48.25% |
| 52-Week Range | ₹76 — ₹151 |
| Sector | Financial Technology (Fintech) |
Strengths
- Sales growth of 35.74% and profit growth of 37.63% show strong momentum
- ROCE of 33.95% indicates efficient capital deployment
- PEG of 0.56 suggests growth may be undervalued relative to earnings expansion
- Piotroski F-Score of 7/9 points to generally sound financial health
- Promoter holding of 48.25% provides reasonable ownership alignment
Concerns
- Latest quarter net profit of ₹5 Cr on ₹139 Cr sales implies a thin net margin
- No dividend, so investor returns depend entirely on reinvestment quality
- Key metrics like book value, ROE, and debt/equity are unavailable, limiting balance sheet visibility
- 52-week range of ₹76 to ₹151 shows significant price volatility
AI Analysis
Finbud Financial strikes me as an interesting compounder, but one needing careful study. A 35.74% sales growth and 37.63% profit growth, with a PEG of 0.56, suggests the market is not fully pricing in its momentum. At ₹132.50, the P/E is 20.47—not cheap in absolute Graham terms, but reasonable if growth persists. The 33.95% ROCE is excellent; it indicates the business employs capital productively. Piotroski F-score of 7/9 adds some comfort on fundamentals. Yet as Graham would say, figures are only the starting point. The latest quarter shows sales of ₹139 Cr but net profit of only ₹5 Cr—a thin net margin. Profit quality matters: a fintech growing sales rapidly while converting a small share to bottom line is vulnerable to credit losses, competition or rising acquisition costs. There is no dividend, so my return depends entirely on management's ability to reinvest at high rates. Promoter holding at 48.25% aligns interests, but I would prefer more skin, and I notice key metrics like book value and ROE are unavailable. Without these, I cannot judge the true cushion or return on equity. The 52-week range of ₹76 to ₹151 also shows a volatile business, not a stable stalwart. I would not buy solely on growth. I need to understand the balance sheet, debt, and unit economics. If the company can maintain 35%+ growth and convert sales to profits more reliably, ₹132.50 may prove reasonable. If not, the market's enthusiasm can reverse quickly. My discipline: only invest where I can see a durable moat and reliable numbers. Finbud is a promising fast grower, but I want more evidence before calling it a wonderful business.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer